Technology News and Research

RSS

First round of financing could make the intelligent bed a reality

At the end of May 2011, two "business angels" and a banking institute invested one million Swiss francs in Michael Sauter's company -compliant concept-. The successful end to this first round of financing is a milestone for the mechanical engineer and young entrepreneur. "This means that the intelligent bed can now become a reality," he says, joyfully.

15 Jul 2011

Inovio reports strong immune responses with VGX-3100 vaccine for cervical dysplasia and cancer

Inovio Pharmaceuticals, Inc., a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, has reported data demonstrating long-term durability of T cell immune responses of up to over two years (at the latest time measured) in 7 of 8 evaluated patients following a fourth vaccination of VGX-3100, its investigational SynCon® DNA vaccine for treating cervical dysplasia and cancer caused by human papillomavirus (HPV) that is delivered using intramuscular electroporation.

15 Jul 2011

Iranian team demonstrates how rapid prototyping can be used in dentistry

Researchers in Iran explain how medical imaging coupled with computer-aided design could be used to create a perfect-fit blueprint for prosthetic dentistry, whether to replace diseased or broken teeth and jaw bone.

15 Jul 2011

Ellipse's MAGEC System can effectively treat children with Early Onset Scoliosis

Ellipse Technologies announced today that preliminary clinical data suggests children with Early Onset Scoliosis (EOS) can be treated safely and effectively without the conventional protocol of repeated surgeries to straighten their growing spine.

15 Jul 2011

B. Braun adds Plasmat Futura System to H.E.L.P. LDL Apheresis therapy

The Renal Therapies Division of B. Braun Medical Inc. (B. Braun) announced today the availability of the Plasmat Futura System for H.E.L.P. LDL Apheresis therapy.

From B. Braun Melsungen AG 15 Jul 2011

IBM, Coriell partner to explore personalized medicine

IBM today announced that Coriell Institute for Medical Research, the largest biobank of living human cells, is using IBM technology to advance its research of human genetic disease and to more efficiently maintain its massive collection of biological resources.

15 Jul 2011

Rcadia reports promising results from calcium scoring cCTA trial

Rcadia Medical Imaging has achieved proof-of-concept with the first fully automated software that performs calcium scoring directly from a coronary CT angiography (cCTA) study.

15 Jul 2011

NSF announces $18.5M grant to establish new engineering research center

The National Science Foundation today announced an $18.5 million grant to establish an Engineering Research Center for Sensorimotor Neural Engineering based at the University of Washington.

15 Jul 2011

Study sheds light on the way antibodies distinguish between different 'biomarkers'

A new research paper sheds light on the way antibodies distinguish between different but closely related 'biomarkers' - proteins which reveal information about the condition of the human body.

15 Jul 2011

IOM releases second report on oral health

On July 13, the Institute of Medicine (IOM) released a second report on oral health, Improving Access to Oral Health Care for Vulnerable and Underserved Populations.

15 Jul 2011

Neuralstem receives U.S. patent allowance for three new neurogenic compounds

Neuralstem, Inc. announced that it has received notice of allowance for U.S. Patent Applications 12/939,897 and 12/939,914 entitled: "Compositions to Effect Neuronal Growth."

15 Jul 2011

Nuvilex to move International Corporate HQ near FDA headquarters

Nuvilex, Inc. announced today it is in the final stages of locating its International Corporate Headquarters near the headquarters of the U.S. Food and Drug Administration.

15 Jul 2011

Scientists identify new metabolic pathway for breast cancer

Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the rapidly emerging field of cancer metabolism, announced today a publication in the journal Nature that identifies dysregulated activity of the serine pathway as a novel metabolic target in certain breast cancers.

15 Jul 2011

Software, No World Borders partner to provide healthcare solutions

No World Borders, Inc., a leading healthcare consulting company, announced that it formed a partnership with Software AG, a global company traded on the Frankfurt stock exchange with over $2.6 billion in market capitalization.

15 Jul 2011

UTHealth enrolls first patient in new stem cell therapy trial for ischemic stroke

The first Texas patient has been enrolled by researchers at The University of Texas Health Science Center at Houston in the country's first double-blind clinical trial studying the safety and efficacy of an innovative stem cell therapy that can be given up to 19 days after an ischemic stroke.

15 Jul 2011

Camel blood can help scientists fight against cancer

Nanobodies produced from camel blood have unique properties, which can be used in future drug development. New research published in Journal of Controlled Release confirms that camel blood can help scientists in the fight against cancer.

15 Jul 2011

OSI Systems introduces Sonicaid Encore to track fetal heartbeat

OSI Systems, Inc., a vertically-integrated provider of specialized electronic products for critical applications in the Security and Healthcare industries, today announced the introduction of the Sonicaid Encore, a high performance fetal and maternal monitor that uses advanced technology for patient monitoring in labor and delivery.

15 Jul 2011

Novel bionic eyes for the blind in the making

British scientists have developed the first pair of bionic glasses that could help thousands of legally blind people. These glasses using tiny cameras and software technology from video games, alert the wearer to objects in their surroundings using flashing lights.

14 Jul 2011

ICON announces acquisition of Firecrest Clinical

ICON plc,, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of Firecrest Clinical, a market-leading provider of technology solutions that boost investigator site performance and study management.

14 Jul 2011

Verastem raises $32 million to develop targeted cancer stem cell therapies

Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, announced today that it has raised $32 million through a Series B financing. Proceeds from the financing will support ongoing research and development and will progress drug candidates into clinical development. The first candidate is projected to enter the clinic in 2012.

14 Jul 2011